Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
AI Tool PrePssmCas Sets New Standard for CRISPR Protein Discovery
Tech & Innovation AI Tool PrePssmCas Sets New Standard for CRISPR Protein Discovery

Small, fast, and precise Cas proteins are the next frontier for gene editing, but finding them requires scanning through massive amounts of genomic noise. In the current scientific landscape of 2026, the sheer volume of data produced by high-throughput sequencing has created a bottleneck that

Biomimetic Nanomedicine Advances Colon Cancer Therapy
Biotech & Bioprocessing Biomimetic Nanomedicine Advances Colon Cancer Therapy

The integration of near-infrared light with gold nanoparticles allows clinicians to thermally destroy cancer cells from the inside out without harming surrounding tissue. This technological breakthrough addresses a critical need in oncology, as colon cancer currently maintains its position as one

FLOURISH Study Validates Osimertinib for Real-World Lung Cancer
Research & Development FLOURISH Study Validates Osimertinib for Real-World Lung Cancer

Baseline next-generation sequencing reveals that over 76 percent of lung cancer patients harbor additional genomic alterations that can shorten treatment durability. This statistic underscores the persistent challenge of managing advanced malignancies outside the sterile confines of traditional

INFORS HT Launches Multifors 3 Bioreactor for Bioprocessing
Management & Regulatory INFORS HT Launches Multifors 3 Bioreactor for Bioprocessing

The Multifors 3 platform revolutionizes documentation by retaining hardware setups and cascade configurations as part of its core reproducibility strategy. This innovative approach to bench-scale bioprocessing arrives at a time when the pharmaceutical industry faces immense pressure to accelerate

ARPA-H Launches $62.7 Million AI Initiative for Heart Care
Tech & Innovation ARPA-H Launches $62.7 Million AI Initiative for Heart Care

By functioning as a clinician-extender, the newly announced ADVOCATE system will autonomously manage heart failure patients between scheduled office visits to improve long-term outcomes. This $62.7 million initiative, launched by the Advanced Research Projects Agency for Health, represents a

Pig Kidney Transplant Sustains Patient for Nine Months
Biotech & Bioprocessing Pig Kidney Transplant Sustains Patient for Nine Months

For Tim Andrews, a 66-year-old patient with Type O blood, the experiment served as a vital bridge to a human transplant after two years of exhaustive waiting. This milestone, achieved through the collaboration of researchers and surgeons at Massachusetts General Hospital, signals a pivotal shift in

Specialty Silicon Drives the Future of Biomanufacturing
Tech & Innovation Specialty Silicon Drives the Future of Biomanufacturing

Technology suppliers are currently focused on removing technical burdens to allow smaller biotech firms to access high-level efficiency and reproducibility. The biomanufacturing industry stands at a critical juncture where the simple accumulation of biological data no longer provides a competitive

Low Spinal Bone Density Linked to Accelerated Brain Aging
Tech & Innovation Low Spinal Bone Density Linked to Accelerated Brain Aging

The architectural integrity of the human skeleton has long been regarded as a separate domain from the intricate cognitive networks of the mind, yet emerging research suggests the spine may serve as a profound biological mirror for neurological health. A comprehensive study from Johns Hopkins

Can a New Gene Therapy Restore Vision in XLRP Patients?
Research & Development Can a New Gene Therapy Restore Vision in XLRP Patients?

For decades, the diagnosis of X-linked retinitis pigmentosa has functioned as a slow-motion countdown toward permanent darkness, leaving thousands of young men to watch their peripheral and night vision slowly fade away without any realistic hope for medical intervention. This devastating genetic

Is Liquid Biopsy the Future of Bladder Cancer Care?
Tech & Innovation Is Liquid Biopsy the Future of Bladder Cancer Care?

The lifelong requirement for invasive cystoscopy surveillance places an immense physical and financial burden on patients diagnosed with recurrent bladder cancer. This burden has sparked a significant paradigm shift in how urothelial carcinoma is managed, steering the medical community away from

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later